The scheme resulted in false payment claims to the federal healthcare program that covers seniors as well as Medicaid, which covers the very poor and disabled. The bribery charges were raised by former employee Michael Bawduniak, who argued Biogen violated the federal Anti-Kickback Statute and the False Claims Act. He will receive about $250million for his role in bringing the allegations to light.